Modulation of Cancer Immunity with Type 2 Innate Lymphoid Cells, Interleukin 33, and/or Interferon Induced Protein 44

• 收藏
• 分享

专利权人:

Wilfred JEFFERIES

发明人:

Wilfred Jefferies,Iryna Yuriyivna Saranchova

申请号：

US15555202

公开号：

US20180050091A1

申请日:

2016.03.03

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention provides methods of modulating of cancer immunity using type 2 innate lymphoid cells (IL-C2s), interleukin 33 (IL-33), IFI44 or combination thereof. Also provided are methods of preventing tumor metastasis and/or cancer progression by treatment with therapies comprising type 2 innate lymphoid cells (ILC2s), interleukin 33 (IL-33), IFI44 or combination thereof. Also provided are diagnostic methods for assessing cancer prognosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/